The AACR Mourns the Loss of Senator Edward Kennedy, Champion of Health Care and Cancer Research
August 26, 2009
PHILADELPHIA - The American Association for Cancer Research celebrates the life and legacy of Senator Edward M. Kennedy (D-Mass.). Over the last half century, Senator Kennedy has stood as a tireless champion in the fight against cancer and was the driving force behind improving health care and research policy in the U.S. Senate.
"Senator Kennedy was a true friend to the cancer research community and he will be remembered with admiration and respect for his extraordinary efforts on behalf of the health and well-being of all Americans," said AACR President Tyler Jacks, Ph.D. "For nearly five decades he stood as an unparalleled champion in the fight against this devastating disease. His efforts will continue to bring us closer to the day when cancer prevention and cures may replace the pain and suffering that many people, himself included, deal with each day around the world. His commitment to our common quest was and will remain an inspiration to us all."
Senator Kennedy first became a cancer research advocate in 1971, when he helped create the National Cancer Act. He played a vital role in various cancer efforts to date, and most recently took on an effort to revisit and improve cancer research and care. Over the past two years, the AACR has worked closely with Senator Kennedy to create the 21st Century Cancer ALERT Act, which establishes provisions to speed cancer research and the translation of innovative research from the lab to therapies needed at the bedside. He was a champion of government support for basic, translational and clinical research aimed at eradicating cancer.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 28,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.